Brainsway (BWAY) Short-term Investments (2025 - 2026)

Brainsway posted quarterly Short-term Investments of $1.1 million for Q1 2026, down 20.53% on a QoQ basis from $1.4 million in Q4 2025.

Brainsway (BWAY) has 2 years of Short-term Investments data on file, last reported at $1.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Short-term Investments changed N/A year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (changed N/A YoY), and the FY2025 full-year result was $1.4 million, changed N/A from the prior year.
  • Short-term Investments for Q1 2026 stood at $1.1 million, down from $1.4 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $1.4 million in Q4 2025 and bottomed at $1.1 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Brainsway 6.80 Mn -52.98 Mn 11.68 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.14 Mn
Dec 31, 2025 1.43 Mn